HUTCHMED (China) Limited (HMDCF)
HUTCHMED (China) Statistics
Share Statistics
HUTCHMED (China) has 871.6M shares outstanding. The number of shares has increased by 0.04% in one year.
| Shares Outstanding | 871.6M |
| Shares Change (YoY) | 0.04% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 72.55 and the forward PE ratio is null. HUTCHMED (China)'s PEG ratio is -1.15.
| PE Ratio | 72.55 |
| Forward PE | n/a |
| PS Ratio | 4.34 |
| Forward PS | n/a |
| PB Ratio | 3.6 |
| P/FCF Ratio | -156.98 |
| PEG Ratio | -1.15 |
Enterprise Valuation
HUTCHMED (China) has an Enterprise Value (EV) of 2.67B.
| EV / Sales | 4.24 |
| EV / EBITDA | 188.72 |
| EV / EBIT | 5378.24 |
| EV / FCF | -153.3 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.83 |
| Quick Ratio | 2.7 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 6.34 |
| Debt / FCF | -5.15 |
| Interest Coverage | -14.14 |
Financial Efficiency
Return on Equity is 4.96% and Return on Invested Capital is -32.95%.
| Return on Equity | 4.96% |
| Return on Assets | 2.96% |
| Return on Invested Capital | -32.95% |
| Revenue Per Employee | $347,985.09 |
| Profits Per Employee | $20,833.24 |
| Employee Count | 1,811 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 6.93 |
Taxes
| Income Tax | 7.19M |
| Effective Tax Rate | -649.68% |
Stock Price Statistics
The stock price has increased by 4.22% in the last 52 weeks. The beta is 0.72, so HUTCHMED (China)'s price volatility has been higher than the market average.
| Beta | 0.72 |
| 52-Week Price Change | 4.22% |
| 50-Day Moving Average | 3.2 |
| 200-Day Moving Average | 3.4 |
| Relative Strength Index (RSI) | 1.11 |
| Average Volume (20 Days) | 63 |
Income Statement
In the last 12 months, HUTCHMED (China) had revenue of 630.2M and earned 37.73M in profits. Earnings per share was 0.04.
| Revenue | 630.2M |
| Gross Profit | 281.32M |
| Operating Income | -40.61M |
| Net Income | 37.73M |
| EBITDA | 14.16M |
| EBIT | 1.76M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 153.96M in cash and 89.82M in debt, giving a net cash position of 64.14M.
| Cash & Cash Equivalents | 153.96M |
| Total Debt | 89.82M |
| Net Cash | 64.14M |
| Retained Earnings | -832.82M |
| Total Assets | 1.27B |
| Working Capital | 689.99M |
Cash Flow
In the last 12 months, operating cash flow was 497K and capital expenditures -17.93M, giving a free cash flow of -17.44M.
| Operating Cash Flow | 497K |
| Capital Expenditures | -17.93M |
| Free Cash Flow | -17.44M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 44.64%, with operating and profit margins of -6.44% and 5.99%.
| Gross Margin | 44.64% |
| Operating Margin | -6.44% |
| Pretax Margin | -0.18% |
| Profit Margin | 5.99% |
| EBITDA Margin | 2.25% |
| EBIT Margin | -6.44% |
| FCF Margin | -2.77% |
Dividends & Yields
HMDCF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.38% |
| FCF Yield | -0.64% |
Analyst Forecast
Currently there are no analyst rating for HMDCF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on May 30, 2019. It was a forward split with a ratio of 10:1.
| Last Split Date | May 30, 2019 |
| Split Type | forward |
| Split Ratio | 10:1 |
Scores
| Altman Z-Score | 3.24 |
| Piotroski F-Score | 2 |